Literature DB >> 9507941

Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients.

M I Aparicio-Legarza1, B Davis, P H Hutson, G P Reynolds.   

Abstract

Saturable radioligand binding of [3H]L-689,560 to the glycine site of the N-methyl-D-aspartate (NMDA) glutamate receptor complex was employed to determine the density of this receptor in putamen, caudate and nucleus accumbens taken post mortem from schizophrenic patients and matched controls. Receptor density was found to be significantly increased in putamen of schizophrenics (P=0.012), although no significant change was found in the other two areas studied. Further experiments following 21 days administration of haloperidol to rats provided no evidence that the increase was related to prior drug treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507941     DOI: 10.1016/s0304-3940(98)00017-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue.

Authors:  B Dean
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

Review 2.  [Effect of antipsychotics on glutaminergic neural transmission in the animal model].

Authors:  A Schmitt; B May; B Müller; M Zink; D F Braus; F A Henn
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

4.  Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study.

Authors:  Lesley A McCollum; Courtney K Walker; Joy K Roche; Rosalinda C Roberts
Journal:  Schizophr Bull       Date:  2015-03-27       Impact factor: 9.306

5.  Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression.

Authors:  S Weis; I C Llenos; J R Dulay; N Verma; S Sabunciyan; R H Yolken
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

6.  Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia.

Authors:  A Schmitt; M Fendt; M Zink; U Ebert; M Starke; M Berthold; A Herb; G Petroianu; P Falkai; F A Henn
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

7.  Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.

Authors:  K A Newell; K Zavitsanou; X-F Huang
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

8.  Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits.

Authors:  Andrea Schmitt; Mathias Zink; Bettina Müller; Brigitte May; Anne Herb; Alexander Jatzko; Dieter F Braus; Fritz A Henn
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

9.  A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.

Authors:  Jeremy S Lum; Samuel J Millard; Xu-Feng Huang; Lezanne Ooi; Kelly A Newell
Journal:  J Psychiatry Neurosci       Date:  2017-10-06       Impact factor: 6.186

Review 10.  The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

Authors:  Peijun Ju; Donghong Cui
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.